Literature DB >> 33070224

Unplanned and medical admissions to pediatric intensive care units significantly decreased during COVID-19 outbreak in Northern Italy.

Francesca Sperotto1,2, Andrea Wolfler3, Paolo Biban4, Luigi Montagnini5, Honoria Ocagli6, Rosanna Comoretto6, Dario Gregori6, Angela Amigoni7.   

Abstract

Northern Italy has been the first European area affected by the COVID-19 pandemic and related social restrictive measures. We sought to evaluate the impact of the COVID-19 outbreak on PICU admissions in Northern Italy, using data from the Italian Network of Pediatric Intensive Care Units Registry. We included all patients admitted to 4 PICUs from 8-weeks-before to 8-weeks-after February 24th, 2020, and those admitted in the same period in 2019. Incidence rate ratios (IRR) evaluating incidence rate differences between pre- and post-COVID-19 periods in 2020 (IRR-1), as well as between the post-COVID-19-period with the same period in 2019 (IRR-2), were computed using zero-inflated negative binomial or Poisson regression modeling. A total of 1001 admissions were included. The number of PICU admissions significantly decreased during the COVID-19 outbreak compared to pre-COVID-19 and compared to the same period in 2020 (IRR-1 0.63 [95%CI 0.50-0.79]; IRR-2 0.70 [CI 0.57-0.91]). Unplanned and medical admissions significantly decreased (IRR-1 0.60 [CI 0.46-0.70]; IRR-2 0.67 [CI 0.51-0.89]; and IRR-1 0.52, [CI 0.40-0.67]; IRR-2 0.77 [CI 0.58-1.00], respectively). Intra-hospital, planned (potentially delayed by at least 12 h), and surgical admissions did not significantly change. Patients admitted for respiratory failure significantly decreased (IRR-1 0.55 [CI 0.37-0.77]; IRR-2 0.48 [CI 0.33-0.69]).Conclusions: Unplanned and medical PICU admissions significantly decreased during COVID-19 outbreak, especially those for respiratory failure. What is Known: • Northern Italy has been the first European area affected by the COVID-19 pandemic. • Although children are relatively spared from the severe COVID-19 disease, the pediatric care system has been affected by social restrictive measures, with a reported 73-88% reduction in pediatric emergency department admissions. What is New: • Unplanned and medical PICU admissions significantly decreased during the COVID-19 outbreak compared to pre-COVID-19 and to the same period in 2019, especially those for respiratory failure. Further studies are needed to identify associated factors and new prevention strategies.

Entities:  

Keywords:  COVID-19; Children; Intensive care; Pandemic; Pediatric critical care; Pediatrics; Public health

Mesh:

Year:  2020        PMID: 33070224      PMCID: PMC7568687          DOI: 10.1007/s00431-020-03832-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


Introduction

Northern Italy has been the first European area in which the COVID-19 pandemic has spread. Although the number of pediatric patients affected by COVID-19 and the severity of symptoms is limited compared to adults [1-4], undirected changes affecting the pediatric care system have been described since the beginning of the outbreak. A recent study reported a 73–88% reduction in pediatric emergency department admissions after the implementation of lockdown measures, compared to the same period in 2018–2019 [5]. Variations in rates and types of admission to the pediatric intensive care units (PICUs) in this period have not yet been investigated. Here, we sought to evaluate the impact of the COVID-19 outbreak and lockdown measures on rates and types of PICU admissions in Northern Italy. To adequately contextualize this analysis, we also evaluated the overall pediatric mortality rate in the same periods and geographic area.

Material and methods

Data source and ethics approval

PICU admission data were extracted from the Italian Network of Pediatric Intensive Care Units (TIPNet) Registry. TIPNet is a Research Network involving 18 Italian PICUs. Ethics Committees of each Center approved the use of the Registry for no-profit research purposes, with a waiver for informed consent due to the observational nature and anonymity of data. Data are prospectively inserted each day of PICU stay into an electronic standardized sheet (REDCap-platform, REDCap, TN, USA). Data are anonymized at the moment of data extraction. Finally, overall mortality data were extracted from the Italian National Institute of Statistics (ISTAT) public repository. All investigations were carried out in accordance with the Declaration of Helsinki.

Study population and data collection

We included all patients admitted to 4 PICUs in Northern Italy (Padova, Verona, Milano, Alessandria) in the period included between 8-weeks-before and 8-weeks-after the first administrative lockdown decree (24th February 2020) [6], and patients admitted in the same period in 2019. All patients admitted to the PICUs were registered. All centers maintained their role of reference for PICU admissions during the COVID-19 outbreak, and no transfer to other centers was registered. Children’s Hospital Vittore Buzzi admitted also adult patients during the outbreak, but pediatric admissions were never readdressed to other centers. The following variables were extracted: age, gender, center of admission, date of admission, type of admission (medical/surgical/traumas, planned/unplanned, intra-hospital/extra-hospital), diagnosis of admission, Pediatric Index of Mortality Score 3 (PIM3) [7], presence of comorbidities, and diagnosis at discharge. Planned admissions were defined as admissions that may be delayed by at least 12 h. For the overall mortality rate analysis, we included all data on residence and mortality regarding the same municipalities involved in the PICU admission analysis.

Statistical analysis

Descriptive data were reported in terms of absolute frequencies for categorical variables, and in terms of medians and interquartile ranges (IQR) for continuous variables. Age and PIM3 values were compared between the 2019 and 2020 cohorts using the Wilcoxon-rank sum test. Incidence rate ratios (IRRs) evaluating incidence rate differences between pre- and post-COVID-19 periods in 2020 (IRR-1), as well as between the post-COVID-19-period with the same period in 2019 (IRR-2), and their 95% confidence intervals were computed using zero-inflated negative binomial or Poisson modeling according to the data distribution, with tuning parameters estimated from data [8, 9]. The zero-inflated method was preferred to account for both possible inflation of categories with no observation and overdispersion in counts data. Nighty-five percent confidence intervals (CIs) were computed using a bootstrapping technique. Finally, the daily mortality rates of the 16-week period in 2019 and of the same period in 2020 were computed as ratios between the daily number of deaths and the population at risk in the same areas. The IRR and 95% CI evaluating the difference in mortality rates between 2019 and 2020 was then computed using a Poisson regression modeling. All statistical analyses were performed using the R statistics statistical software (version 3.6.2., R Core Team, R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was set at a two-sided p value < 0.05.

Results

Study population

Overall, 1001 patients were included. Over the course of the 2020 16-week period, a total of 443 patients were admitted to the 4 PICUs (9 [2%] affected by COVID-19). In the same period in 2019, 558 patients were admitted to the same centers. The median age was 0.9 years in the 2019 cohort (interquartile range [IQR] 0.1–5.0), and 1.2 years (IQR 0.2–5.9) in the 2020 cohort (p = 0.103). The PIM3 score was similar in the two cohorts (0.009 [IQR 0.004–0.032] vs 0.008 [IQR 0.005, 0.035], p = 0.94).

Frequency of PICU admissions and incidence rate ratios

Characteristics, frequencies of PICU admissions, and estimated IRRs are shown in Table 1. Overall, the number of PICU admissions significantly decreased by 37% compared to pre-COVID-19 (IRR-1 0.63 [CI 0.50–0.79]) and by 30% compared to 2019 (IRR-2 0.70 [CI 0.57–0.91]) (Fig. 1). PICU admissions decreased especially among patients < 1 year (IRR-1 0.64 [CI 0.47–0.91]), but this is not significant when compared to 2019. Unplanned admissions decreased by 40% compared to pre-COVID-19 (IRR-1 0.60 [CI 0.46–0.70]) and by 37% compared to 2019 (IRR-2 0.67 [CI 0.51–0.89]). Medical admissions decreased by 50% compared to pre-COVID-19 (IRR-1 0.52, [CI 0.40–0.67]) and by 23% compared to 2019 (IRR-2 0.77 [CI 0.58–1.00]. Extra-hospital admissions decreased by 50% compared to pre-COVID-19 (IRR-1 0.50 [CI 0.37–0.65]) and by 30% compared to 2019 (IRR-1 0.70 [CI 0.52–0.97]). Intra-hospital, planned, and surgical admissions did not significantly change. Patients admitted for respiratory failures decreased by 45% compared to pre-COVID-19 (IRR-1 0.55 [CI 0.37–0.77]) and by 52% compared to 2019 (IRR-2 0.48 [CI 0.33–0.69]). Other admission or discharge diagnoses did not significantly differ. Patients with comorbid conditions were admitted significantly less frequently during COVID-19 outbreak compared to the pre-COVID-19 period (IRR 0.73 [0.56–0.96]), but did not significantly differ from 2019.
Table 1

Characteristics and frequency of admissions to pediatric intensive care units, and estimates of incidence rate ratios (IRR)

VariableIRR-1 (pre- vs post 2020)95% confidence intervalIRR-2 (post 2019 vs post 2020)95% confidence interval20192020
N, pre-Feb 24N, post-Feb 24N, tot 2019N, pre-Feb 24N, post-Feb 24N, tot 2020
Admissions, overall0.630.50–0.790.700.57–0.91299259558277166443
Gender

Female

Male

0.71

0.69

0.52–0.98

0.53–0.90

0.79

0.83

0.57–1.08

0.63–1.11

134

165

110

149

244

314

115

162

62

104

177

266

Age

0–1 year

1–3 years

3–6 years

> 6 years

0.65

0.71

0.97

0.80

0.47–0.91

0.41–1.17

0.55–1.65

0.54–1.18

0.90

0.80

0.86

0.80

0.64–1.24

0.47–1.31

0.51–1.43

0.55–1.15

145

50

29

61

94

45

43

70

239

95

72

131

139

46

24

58

65

24

22

42

204

70

46

100

Type of admission

Extra-hospital

Intra-hospital, ward

Intra-hospital, surgery

0.50

0.80

1.02

0.37–0.65

0.52–1.21

0.69–1.62

0.70

1.01

0.85

0.52–0.97

0.66–1.57

0.60–1.24

190

49

49

130

44

72

320

93

121

175

49

45

77

31

49

252

80

94

Planned

Unplanned

0.86

0.60

0.55–1.32

0.46–0.78

0.93

0.67

0.60–1.36

0.51–0.89

56

225

73

170

129

395

75

184

45

99

120

283

Diagnosis at admission

Medical

Respiratory failure

Sensory impairment/seizure

Metabolic/dehydration

Cardiovascular, congenital

Heart failure

Sepsis

Others

Surgical

Traumas

0.52

0.55

0.70

1.25

1.00b

0.57

1.00b

0.89

0.86

1.00b

0.40–0.67

0.37–0.77

0.30–1.50

0.28–4.67

0.37–2.72

0.21–2.21

0.26–3.31

0.48–1.67

0.63–1.24

0.11 – c

0.77

0.48

0.94

0.71

-d

1.13

1.00b

0.83

0.87

0.79

0.58–1.00

0.33–0.69

0.43–2.08

0.14–4.03

-

0.52–3.42

0.24–4.91

0.41–1.63

0.62–1.23

0.26–2.08

213

139

28

7

1

7

2

21

56

12

147

87

18

11

1

6

6

15

83

15

360

226

46

18

2

13

8

36

139

27

206

133

20

8

9

6

7

15

68

2

98

42

9

5

6

17

4

13

62

6

304

175

29

13

15

23

11

28

130

8

Patient complexity

Baseline comorbid conditions

No comorbid conditions

0.73

0.62

0.56–0.96

0.43–0.84

1.03

0.69

0.79–1.39

0.50–0.95

87

195

93

151

180

346

128

148

90

76

218

224

Diagnosis at dischargea

Respiratory, upper tract

Respiratory, lower tract

Respiratory, other

Cardiovascular, congenital

Cardiovascular, acquired

Neurologic

Gastrointestinal

Others

1.23

0.54

0.94

0.90

0.83

0.79

1.14

0.82

0.46–3.03

0.30–0.94

0.55–1.64

0.54–1.68

0.31–2.53

0.47–1.33

0.53–2.88

0.52–1.27

1.20

0.78

0.64

1.09

1.23

0.89

0.97

0.53

0.35–6.66

0.43–1.53

0.35–1.02

0.61–1.93

0.42–5.67

0.52–1.46

0.48–2.13

0.35–0.86

7

83

47

18

9

37

10

73

5

29

55

17

3

33

13

83

12

112

102

35

12

70

23

156

11

82

32

27

6

33

7

52

6

14

20

22

16

23

16

29

17

96

52

49

22

56

23

81

Incidence rate ratios are IRR-1, pre-COVID-19 incidence rate vs post-COVID-19 incidence rate in 2020; IRR-2, post-COVID-19 incidence rate in 2019 vs the incidence rate of the same period in 2020. a37 patients were still in the PICU at the moment of data analysis; thus, no diagnosis at discharge was entered. bIRR computed using zero-inflated Poisson regression modeling due to different data distribution. cInfinite upper bounds. dIRR and CI were not reliable due to the small numerosity of the subgroup. Missing data: n (2019, 2020): age: 44 (21, 23); type of admission extra/-hospital/intra-hospital/surgery: 41 (24, 17); planned/not planned: 74 (34, 40); diagnosis at admission: 32 (31, 1); comorbid conditions: 33 (32, 1); diagnosis at discharge 4 (4, 0). IRR, incidence rate ratio

Fig. 1

a Overall trend of admissions to pediatric intensive care units in 2020 and 2019; b Trend of unplanned admissions; c Trend of admissions of patients with respiratory failure. Data refer to the period included from 8-weeks-before to 8-weeks-after the first administrative lockdown decree (24th February, green line). Lines represent the incidence rate and 95% confidence interval (dark gray area) modeling over time. Incidence rates and incidence rate ratios evaluating incidence rate differences between pre- and post-COVID-19 periods in 2020 (IRR-1), as well as between the post-COVID-19-period with the same period in 2019 (IRR-2), were computed using zero-inflated negative binomial or Poisson regression modeling, and bootstrapping process for CIs. N is the total count per subgroup

Characteristics and frequency of admissions to pediatric intensive care units, and estimates of incidence rate ratios (IRR) Female Male 0.71 0.69 0.52–0.98 0.53–0.90 0.79 0.83 0.57–1.08 0.63–1.11 134 165 110 149 244 314 115 162 62 104 177 266 0–1 year 1–3 years 3–6 years > 6 years 0.65 0.71 0.97 0.80 0.47–0.91 0.41–1.17 0.55–1.65 0.54–1.18 0.90 0.80 0.86 0.80 0.64–1.24 0.47–1.31 0.51–1.43 0.55–1.15 145 50 29 61 94 45 43 70 239 95 72 131 139 46 24 58 65 24 22 42 204 70 46 100 Extra-hospital Intra-hospital, ward Intra-hospital, surgery 0.50 0.80 1.02 0.37–0.65 0.52–1.21 0.69–1.62 0.70 1.01 0.85 0.52–0.97 0.66–1.57 0.60–1.24 190 49 49 130 44 72 320 93 121 175 49 45 77 31 49 252 80 94 Planned Unplanned 0.86 0.60 0.55–1.32 0.46–0.78 0.93 0.67 0.60–1.36 0.51–0.89 56 225 73 170 129 395 75 184 45 99 120 283 Medical Respiratory failure Sensory impairment/seizure Metabolic/dehydration Cardiovascular, congenital Heart failure Sepsis Others Surgical Traumas 0.52 0.55 0.70 1.25 1.00b 0.57 1.00b 0.89 0.86 1.00b 0.40–0.67 0.37–0.77 0.30–1.50 0.28–4.67 0.37–2.72 0.21–2.21 0.26–3.31 0.48–1.67 0.63–1.24 0.11 – c 0.77 0.48 0.94 0.71 -d 1.13 1.00b 0.83 0.87 0.79 0.58–1.00 0.33–0.69 0.43–2.08 0.14–4.03 - 0.52–3.42 0.24–4.91 0.41–1.63 0.62–1.23 0.26–2.08 213 139 28 7 1 7 2 21 56 12 147 87 18 11 1 6 6 15 83 15 360 226 46 18 2 13 8 36 139 27 206 133 20 8 9 6 7 15 68 2 98 42 9 5 6 17 4 13 62 6 304 175 29 13 15 23 11 28 130 8 Baseline comorbid conditions No comorbid conditions 0.73 0.62 0.56–0.96 0.43–0.84 1.03 0.69 0.79–1.39 0.50–0.95 87 195 93 151 180 346 128 148 90 76 218 224 Respiratory, upper tract Respiratory, lower tract Respiratory, other Cardiovascular, congenital Cardiovascular, acquired Neurologic Gastrointestinal Others 1.23 0.54 0.94 0.90 0.83 0.79 1.14 0.82 0.46–3.03 0.30–0.94 0.55–1.64 0.54–1.68 0.31–2.53 0.47–1.33 0.53–2.88 0.52–1.27 1.20 0.78 0.64 1.09 1.23 0.89 0.97 0.53 0.35–6.66 0.43–1.53 0.35–1.02 0.61–1.93 0.42–5.67 0.52–1.46 0.48–2.13 0.35–0.86 7 83 47 18 9 37 10 73 5 29 55 17 3 33 13 83 12 112 102 35 12 70 23 156 11 82 32 27 6 33 7 52 6 14 20 22 16 23 16 29 17 96 52 49 22 56 23 81 Incidence rate ratios are IRR-1, pre-COVID-19 incidence rate vs post-COVID-19 incidence rate in 2020; IRR-2, post-COVID-19 incidence rate in 2019 vs the incidence rate of the same period in 2020. a37 patients were still in the PICU at the moment of data analysis; thus, no diagnosis at discharge was entered. bIRR computed using zero-inflated Poisson regression modeling due to different data distribution. cInfinite upper bounds. dIRR and CI were not reliable due to the small numerosity of the subgroup. Missing data: n (2019, 2020): age: 44 (21, 23); type of admission extra/-hospital/intra-hospital/surgery: 41 (24, 17); planned/not planned: 74 (34, 40); diagnosis at admission: 32 (31, 1); comorbid conditions: 33 (32, 1); diagnosis at discharge 4 (4, 0). IRR, incidence rate ratio a Overall trend of admissions to pediatric intensive care units in 2020 and 2019; b Trend of unplanned admissions; c Trend of admissions of patients with respiratory failure. Data refer to the period included from 8-weeks-before to 8-weeks-after the first administrative lockdown decree (24th February, green line). Lines represent the incidence rate and 95% confidence interval (dark gray area) modeling over time. Incidence rates and incidence rate ratios evaluating incidence rate differences between pre- and post-COVID-19 periods in 2020 (IRR-1), as well as between the post-COVID-19-period with the same period in 2019 (IRR-2), were computed using zero-inflated negative binomial or Poisson regression modeling, and bootstrapping process for CIs. N is the total count per subgroup

Overall mortality rate analysis

The overall pediatric mortality rate computed for the same geographic area in the 2020 16-week study period did not significantly differ from 2019 (IRR 1.23 [CI 0.60–2.53], Supplemental Figure 1).

Discussion

With this study, we have shown that unplanned and medical PICU admissions significantly decreased during the COVID-19 outbreak compared to pre-COVID-19 and to 2019. Particularly, PICU admissions for respiratory failure significantly decreased compared to pre-COVID-19 and to 2019. A decrease in PICU admissions could have been theoretically expected due to the reorganization of elective-care within medical and surgical departments. However, our findings showed that planned admissions did not significantly change. This can be explained by the fact that “planned” PICU activity cannot be considered as a direct synonym of “elective,” since often involves critically patients whose admission can be delayed only by few hours or days (e.g., patients needed monitoring during infusions or procedures, vascular lines placements, etc.). Additionally, even if a large number of surgeries were postponed during the COVID-19-outbreak worldwide, it is also true that urgent interventions were not delayed, and those interventions usually represent the most significant determinant in the number of surgical PICU admissions. Conversely, we found that unplanned medical admissions significantly decreased. Prevention of PICU admissions—i.e., reducing the number of patients who present with critical and life-threatening conditions—has been one of the main goals of the pediatric modern medicine. Here, we are looking at an event that has spontaneously reduced the PICU admissions by 30–50%. Although we do not have a clear scientific explanation of this phenomenon, we believe this represents an important message to the scientific community and Health Systems. We may speculate that the implementation of lockdown measures [6], social distancing, mask-wearing, travel restriction, and the consolidation of the hygiene practices might have reduced the transmission of other respiratory pathogens. Certainly, the human being cannot live under restrictive measures forever, but if restrictive measures were able to significantly reduce the rate of PICU admissions, it is worthy to analyze which measures can be reproduced within a healthy and constructive approach, e.g., reorganization of day cares or increasing the awareness on the importance to isolate symptomatic subjects. An additional finding of our analysis was that the trend of admissions of comorbid patients significantly decreased during the outbreak, although it is not significantly different from 2019. Since comorbid patients are at higher risk of both PICU admission and COVID-19 disease, we could hypothesize that an effective strategy of domiciliary care might have been implemented during the outbreak for these patients. It is also possible that comorbid patients refrained from seeking specialized care during the outbreak. However, a spontaneous resolution of a moderate disease in comorbid patients would be extremely rare, and the overall mortality rate did not significantly differ from 2019. Some limitations should be taken into consideration when interpreting these results. Although data were prospectively collected and all admitted patients were included in the registry, this remains a retrospective analysis and a small amount of data was missing. Additionally, no data regarding specific respiratory pathogens (other than COVID-19) were included. Finally, it was not possible to stratify the severity of comorbid conditions. In conclusion, our study showed that unplanned and medical PICU admissions, especially those for respiratory failure, significantly decreased during COVID-19-outbreak. Further studies are needed to address the complex reasons underlying these significant changes, but we believe this report can guide and help physicians and health systems in being aware of the complex adjustments of events around a pandemic and identifying new strategies of prevention. Trend of mortality rate in the pediatric population of the same geographic area in the same 2019 and 2020 periods. Data refer to the period included from 8-weeks-before to 8-weeks-after the first administrative lockdown decree (24th February, blue vertical line). Lines represent the incidence rate and 95% confidence interval (dark gray area) modeling over time. Incidence rates and incidence rate ratios and their 95% confidence intervals were computed using Poisson regression modeling, and bootstrapping process for CIs. (DOCX 36 kb)

What is Known:

• Northern Italy has been the first European area affected by the COVID-19 pandemic.

• Although children are relatively spared from the severe COVID-19 disease, the pediatric care system has been affected by social restrictive measures, with a reported 7388% reduction in pediatric emergency department admissions.

What is New:

• Unplanned and medical PICU admissions significantly decreased during the COVID-19 outbreak compared to pre-COVID-19 and to the same period in 2019, especially those for respiratory failure. Further studies are needed to identify associated factors and new prevention strategies.

  6 in total

1.  Paediatric index of mortality 3: an updated model for predicting mortality in pediatric intensive care*.

Authors:  Lahn Straney; Archie Clements; Roger C Parslow; Gale Pearson; Frank Shann; Jan Alexander; Anthony Slater
Journal:  Pediatr Crit Care Med       Date:  2013-09       Impact factor: 3.624

2.  Epidemiology of COVID-19 Among Children in China.

Authors:  Yuanyuan Dong; Xi Mo; Yabin Hu; Xin Qi; Fan Jiang; Zhongyi Jiang; Shilu Tong
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

3.  Children with Covid-19 in Pediatric Emergency Departments in Italy.

Authors:  Niccolò Parri; Matteo Lenge; Danilo Buonsenso
Journal:  N Engl J Med       Date:  2020-05-01       Impact factor: 91.245

4.  Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.

Authors:  Silvia Garazzino; Carlotta Montagnani; Daniele Donà; Antonella Meini; Enrico Felici; Gianluca Vergine; Stefania Bernardi; Roberta Giacchero; Andrea Lo Vecchio; Paola Marchisio; Giangiacomo Nicolini; Luca Pierantoni; Ivana Rabbone; Giuseppe Banderali; Marco Denina; Elisabetta Venturini; Andrzej Krzysztofiak; Raffaele Badolato; Sonia Bianchini; Luisa Galli; Alberto Villani; Guido Castelli-Gattinara
Journal:  Euro Surveill       Date:  2020-05

5.  Delayed access or provision of care in Italy resulting from fear of COVID-19.

Authors:  Marzia Lazzerini; Egidio Barbi; Andrea Apicella; Federico Marchetti; Fabio Cardinale; Gianluca Trobia
Journal:  Lancet Child Adolesc Health       Date:  2020-04-09

6.  Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.

Authors:  Lara S Shekerdemian; Nabihah R Mahmood; Katie K Wolfe; Becky J Riggs; Catherine E Ross; Christine A McKiernan; Sabrina M Heidemann; Lawrence C Kleinman; Anita I Sen; Mark W Hall; Margaret A Priestley; John K McGuire; Konstantinos Boukas; Matthew P Sharron; Jeffrey P Burns
Journal:  JAMA Pediatr       Date:  2020-09-01       Impact factor: 16.193

  6 in total
  11 in total

1.  Impact of the COVID-19 Outbreak on Disease Spectrum of Pediatric Intensive Care Units.

Authors:  Wen Jing Li; Chun Ling Xue; Zhuo Li
Journal:  Front Med (Lausanne)       Date:  2022-05-10

2.  Pediatric admissions to emergency departments of North-Western Italy during COVID-19 pandemic: A retrospective observational study.

Authors:  Irene Raffaldi; Emanuele Castagno; Ilaria Fumi; Claudia Bondone; Fulvio Ricceri; Luigi Besenzon; Adalberto Brach Del Prever; Pina Capalbo; Gianluca Cosi; Enrico Felici; Patrizia Fusco; Maria Rita Gallina; Franco Garofalo; Paola Gianino; Andrea Guala; Oscar Haitink; Paolo Manzoni; Antonio Marra; Ivana Rabbone; Luca Roasio; Savino Santovito; Alberto Serra; Eleonora Tappi; Gian Maria Terragni; Fabio S Timeus; Flaminia Torielli; Alessandro Vigo; Antonio F Urbino
Journal:  Lancet Reg Health Eur       Date:  2021-03-18

3.  Changes in pediatric infections during the COVID-19 pandemic: 'a quarantrend for coronials'?

Authors:  Jaan Toelen; Nicole Ritz; J Peter de Winter
Journal:  Eur J Pediatr       Date:  2021-06       Impact factor: 3.183

Review 4.  Italian neonatologists and SARS-CoV-2: lessons learned to face coming new waves.

Authors:  Maria Elena Cavicchiolo; Daniele Trevisanuto; Elena Priante; Laura Moschino; Fabio Mosca; Eugenio Baraldi
Journal:  Pediatr Res       Date:  2021-04-07       Impact factor: 3.953

5.  Changes in pediatric healthcare utilization in Hunan Province, China, during the COVID-19 pandemic: a multi-center cross-sectional study.

Authors:  Haipeng Yan; Xun Li; Xiulan Lu; Saizhen Zeng; Yuanhong Yuan; Xian Hu; Yimin Zhu; Zhenghui Xiao
Journal:  Transl Pediatr       Date:  2021-04

6.  Impact of the COVID-19 Pandemic on the Frequency, Clinical Spectrum and Outcomes of Pediatric Guillain-Barré Syndrome in India: A Multicentric Ambispective Cohort Study.

Authors:  Divyani Garg; Rajinder K Dhamija; Aditya Choudhary; Ritu Shree; Sujit Kumar; Priyanka Samal; Abhishek Pathak; Pamidimukkala Vijaya; Yareeda Sireesha; Sruthi S Nair; Sanjay Sharma; Soaham Desai; Human P Sinha; Ayush Agarwal; Ashish Upadhyay; M V Padma Srivastava; Rohit Bhatia; Awadh K Pandit; Rajesh K Singh; Alisha Reyaz; P M Yogeesh; Manish Salunkhe; Vivek Lal; Manish Modi; Gagandeep Singh; Monika Singla; Samhita Panda; Maya Gopalakrishnan; Inder Puri; Sudhir Sharma; Bismay Kumar; Prashant K Kushwaha; Harshadkumar Chovatiya; Teresa Ferreira; Sanjeev K Bhoi; Manish Bhartiya; Subhash Kaul; Anuja Patil; Neeharika L Mathukumalli; Madhu Nagappa; P Praveen Sharma; Aneesh Basheer; Dileep Ramachandran; Neetha Balaram; Jospeh Sebastian; Venugopalan Y Vishnu
Journal:  Ann Indian Acad Neurol       Date:  2021-11-17       Impact factor: 1.383

7.  Effects of COVID-19 pandemic restrictions on an Australian neonatal and paediatric retrieval service.

Authors:  Amy Keir; Jeffrey Dutschke; Bron Hennebry; Kate Kerin; John Craven
Journal:  J Paediatr Child Health       Date:  2022-02-28       Impact factor: 1.929

8.  Consequences of Social Distancing Measures During the COVID-19 Pandemic First Wave on the Epidemiology of Children Admitted to Pediatric Emergency Departments and Pediatric Intensive Care Units: A Systematic Review.

Authors:  Michael Levy; Victor Lestrade; Carla Said; Philippe Jouvet; Atsushi Kawaguchi
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

9.  Impact of COVID-19 on Respiratory Admissions in a Tertiary Pediatric Intensive Care Unit.

Authors:  Shashikanth Ambati; Maya Mihic; Kristy Wilkinson; Javier L Sanchez; Chad Pezzano
Journal:  Cureus       Date:  2022-05-26

10.  Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.

Authors:  Michelle W Rudolph; Sjoerdtje Slager; Johannes G M Burgerhof; Job B M van Woensel; Jan-Willem C Alffenaar; Roelie M Wösten-van Asperen; Matthijs de Hoog; Marloes M IJland; Martin C J Kneyber
Journal:  Trials       Date:  2022-01-31       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.